CA2857043C - Composition a base de silicone pour le traitement de la peau - Google Patents
Composition a base de silicone pour le traitement de la peau Download PDFInfo
- Publication number
- CA2857043C CA2857043C CA2857043A CA2857043A CA2857043C CA 2857043 C CA2857043 C CA 2857043C CA 2857043 A CA2857043 A CA 2857043A CA 2857043 A CA2857043 A CA 2857043A CA 2857043 C CA2857043 C CA 2857043C
- Authority
- CA
- Canada
- Prior art keywords
- silicone
- based gel
- approximately
- active ingredient
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201113337614A | 2011-12-27 | 2011-12-27 | |
| US13/337,614 | 2011-12-27 | ||
| US13/564,467 US9592241B2 (en) | 2011-12-27 | 2012-08-01 | Silicone-based composition for skin treatment |
| US13/564,467 | 2012-08-01 | ||
| PCT/US2012/071818 WO2013101929A1 (fr) | 2011-12-27 | 2012-12-27 | Composition à base de silicone pour le traitement de la peau |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2857043A1 CA2857043A1 (fr) | 2013-07-04 |
| CA2857043C true CA2857043C (fr) | 2016-01-05 |
Family
ID=48655158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2857043A Expired - Fee Related CA2857043C (fr) | 2011-12-27 | 2012-12-27 | Composition a base de silicone pour le traitement de la peau |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US9592241B2 (fr) |
| EP (1) | EP2797593A4 (fr) |
| AU (1) | AU2012362398A1 (fr) |
| CA (1) | CA2857043C (fr) |
| WO (1) | WO2013101929A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9592241B2 (en) | 2011-12-27 | 2017-03-14 | Cmpd Licensing, Llc | Silicone-based composition for skin treatment |
| WO2015081007A1 (fr) * | 2013-11-26 | 2015-06-04 | Humco Holding Group, Inc. | Compositions de gel de silicone (silogel) transdermiques et procédés de préparation |
| US9511034B1 (en) | 2013-12-09 | 2016-12-06 | Bio-Silicote, Inc. | Method for applying a skin treatment |
| US11446236B2 (en) | 2015-08-05 | 2022-09-20 | Cmpd Licensing, Llc | Topical antimicrobial compositions and methods of formulating the same |
| US11793783B2 (en) | 2015-08-05 | 2023-10-24 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| US11684567B2 (en) | 2015-08-05 | 2023-06-27 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
| CN108403623A (zh) * | 2018-05-29 | 2018-08-17 | 南京华开生物科技有限公司 | 硅酮疤痕凝胶 |
| WO2020178005A1 (fr) * | 2019-03-01 | 2020-09-10 | Wasserman Medic AB | Nouvelles compositions et leur utilisation |
| WO2022119428A1 (fr) * | 2020-12-04 | 2022-06-09 | Laboratorios Silanes S.A. De C.V. | Combinaison pharmaceutique d'un corticostéroïde et d'un antihistaminique pour le traitement et la régulation du composant inflammatoire de processus allergiques |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6472165B1 (en) * | 1999-08-03 | 2002-10-29 | Arzneimittelwerk Dresden Gmbh | Modulatory binding site in potassium channels for screening and finding new active ingredients |
| GB0007140D0 (en) | 1999-09-27 | 2000-05-17 | Dow Corning Sa | Scar treatment composition |
| US10179159B2 (en) * | 1999-10-22 | 2019-01-15 | Scott Wepfer | Topical anesthetic formulation |
| US6337076B1 (en) | 1999-11-17 | 2002-01-08 | Sg Licensing Corporation | Method and composition for the treatment of scars |
| US6673363B2 (en) * | 1999-12-16 | 2004-01-06 | Dermatrends, Inc. | Transdermal and topical administration of local anesthetic agents using basic enhancers |
| US20050014729A1 (en) | 2003-07-16 | 2005-01-20 | Pharmacia Corporation | Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith |
| US20050267258A1 (en) * | 2004-05-26 | 2005-12-01 | Rajaraman Suresh K | Evaporable silicone carriers for cosmetics, cleaning and care product compositions |
| US20060013866A1 (en) * | 2004-07-16 | 2006-01-19 | Carter Stephen G | Transdermal drug delivery formulations with optimal amounts of vasodilators therein |
| US8557287B2 (en) | 2004-08-06 | 2013-10-15 | Jeff S. Schleuning | Silicone gel composition and dispenser therefor |
| US20080153786A1 (en) * | 2006-05-22 | 2008-06-26 | Galderma S.A. | Controlled release of drugs into/through the skin |
| US20110046532A1 (en) | 2006-01-30 | 2011-02-24 | Sanjeev Kaila | composition including a silicone-based polymer and a method of treating skin disorders using the composition |
| CA2644311C (fr) | 2006-03-01 | 2012-07-10 | Tristrata, Inc. | Compositions et procedes pour le traitement topique de troubles dermatologiques repondants au goudron |
| TW200932292A (en) | 2007-09-30 | 2009-08-01 | Valeant Pharmaceuticals Int | Silicone gel-based compositions for wound healing and scar reduction |
| WO2010036937A1 (fr) | 2008-09-27 | 2010-04-01 | Taraxos Inc. | Formulations topiques pour le traitement d’une neuropathie |
| US20100322875A1 (en) | 2009-06-18 | 2010-12-23 | Advanced Bio-Technologies, Inc. | Silicone scar treatment preparation |
| WO2011022652A1 (fr) | 2009-08-21 | 2011-02-24 | Novan, Inc. | Gels topiques |
| US9592241B2 (en) | 2011-12-27 | 2017-03-14 | Cmpd Licensing, Llc | Silicone-based composition for skin treatment |
-
2012
- 2012-08-01 US US13/564,467 patent/US9592241B2/en not_active Expired - Fee Related
- 2012-12-27 CA CA2857043A patent/CA2857043C/fr not_active Expired - Fee Related
- 2012-12-27 EP EP12861595.2A patent/EP2797593A4/fr not_active Withdrawn
- 2012-12-27 WO PCT/US2012/071818 patent/WO2013101929A1/fr not_active Ceased
- 2012-12-27 AU AU2012362398A patent/AU2012362398A1/en not_active Abandoned
-
2015
- 2015-03-10 US US14/643,704 patent/US9271989B2/en active Active
-
2017
- 2017-03-13 US US15/457,003 patent/US10064949B2/en active Active
-
2018
- 2018-09-04 US US16/121,184 patent/US10660962B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20170182167A1 (en) | 2017-06-29 |
| EP2797593A4 (fr) | 2014-12-17 |
| US9271989B2 (en) | 2016-03-01 |
| CA2857043A1 (fr) | 2013-07-04 |
| US10064949B2 (en) | 2018-09-04 |
| US20190060464A1 (en) | 2019-02-28 |
| US9592241B2 (en) | 2017-03-14 |
| EP2797593A1 (fr) | 2014-11-05 |
| US10660962B2 (en) | 2020-05-26 |
| US20150182538A1 (en) | 2015-07-02 |
| WO2013101929A1 (fr) | 2013-07-04 |
| AU2012362398A1 (en) | 2014-08-21 |
| US20130165420A1 (en) | 2013-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10660962B2 (en) | Silicone-based composition for skin treatment | |
| US10085995B2 (en) | Topical compositions and methods of treatment of anorectal disorders | |
| US20110009374A1 (en) | Method of wound healing and scar modulation | |
| PL207845B1 (pl) | Spray donosowy do dostarczania kompozycji farmaceutycznej zawierającej fentanyl i zastosowanie soli fentanylu do wytwarzania środka leczniczego | |
| EP3071295A2 (fr) | Procédés, compositions et dispositifs anti-infectieux | |
| AU2009348848B2 (en) | Method for treating or ameliorating mucocutaneous or ocular toxicities | |
| JP2024138267A (ja) | 真皮保護剤および担体 | |
| Christensen et al. | Safety and efficacy of intranasal ketamine for acute postoperative pain | |
| JP2015530380A (ja) | 乾癬を治療するための組成物 | |
| US20080220068A1 (en) | Treatment and prevention of excessive scarring | |
| CN112020352A (zh) | 用于痤疮的大麻素给药方案 | |
| WO2006014259A1 (fr) | Composition et méthode de traitement des hémorroïdes et/ou troubles anorectaux | |
| EP2046310B1 (fr) | Traitement et prévention de la cicatrisation pathologique | |
| US20220249512A1 (en) | Topical pharmaceutical compositions comprising diltiazem | |
| EP1891945A1 (fr) | Traitement et prévention des excès cicatriciels | |
| HK1130434B (en) | Treatment and prevention of excessive scarring |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20140526 |
|
| MKLA | Lapsed |
Effective date: 20171227 |